The Community Doctor: Local Food, Real Health & Prevention
Virginia family physician Dr. Brooke Miller on leaving the corporate system to revive the community doctor who knew every family he treated.
Here’s a Thought: Being Human Isn’t a Medical Condition
And not every uncomfortable emotion is a pathology.
From Snake Oil to Big Pharma: The Long Battle Between Fraud, Innovation, Regulation, and Profit
When medicine feels distant, expensive, or dismissive, patients become more vulnerable to promises from outside the system. That lesson still applies today.
Medicine at 250 Years: Balancing Technology and the Human Touch
Technology has transformed medicine, but it can't replace personal care. IMA Senior Fellow Dr. Mollie James on restoring the doctor-patient relationship.
The Flexner Turning Point: How Scientific Medicine Raised Standards and Narrowed the Field
The Flexner Report helped raise standards at a time when standards were needed. But reform is never only about improvement. It is also about power.
Medicine at 250 Years: Putting Patients Back in Charge
Texas family physician Dr. Kat Lindley shares how direct primary care cuts out the middlemen and puts patients back in charge of their healthcare.
When Medicine Became a Profession: Medical Schools, Licensing, and the Rise of Scientific Authority
The question is whether medicine can preserve scientific rigor without losing the independent physician, the informed patient, and the human relationship at the center of care.
Medicine at 250 Years: Why the Next Era Must Restore Trust
As America marks 250 years, Dr. Joseph Varon reflects on medicine's roots and calls for restoring trust, consent, and the doctor-patient relationship.
The Home Was the First Clinic: American Medicine Before the System
Before medicine became a system, care was personal, local, and built on relationships. As America marks 250 years, IMA explores what modern medicine must restore.
Ivermectin Is on Trial Again. This Time, It’s Cancer.
The largest oncology society in America just recommended against ivermectin and fenbendazole in cancer. Dr. Marik argues the evidence standard was never built for these drugs.
